{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:14:14Z","timestamp":1769764454733,"version":"3.49.0"},"reference-count":45,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2013,9,3]],"date-time":"2013-09-03T00:00:00Z","timestamp":1378166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The growth and vascularization of prostate cancer is dependent on interactions between cancer cells and supporting stromal cells. The primary stromal cell type found in prostate tumors is the carcinoma-associated fibroblast, which produces placental growth factor (PlGF). PlGF is a member of the vascular endothelial growth factor (VEGF) family of angiogenic molecules and PlGF mRNA levels increase after androgen deprivation therapy in prostate cancer. In this study, we show that PlGF has a direct dose-dependent proliferative effect on human PC-3 prostate cancer cells in vitro and fibroblast-derived PlGF increases PC-3 proliferation in co-culture. In xenograft tumor models, intratumoral administration of murine PlGF siRNA reduced stromal-derived PlGF expression, reduced tumor burden and decreased the number of Ki-67 positive proliferating cells associated with reduced vascular density. These data show that targeting stromal PlGF expression may represent a therapeutic target for the treatment of prostate cancer.<\/jats:p>","DOI":"10.3390\/ijms140917958","type":"journal-article","created":{"date-parts":[[2013,9,3]],"date-time":"2013-09-03T12:43:48Z","timestamp":1378212228000},"page":"17958-17971","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Inhibition of Stromal PlGF Suppresses the Growth of Prostate Cancer Xenografts"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0202-2364","authenticated-orcid":false,"given":"Karin","family":"Zins","sequence":"first","affiliation":[{"name":"Laboratory for Molecular Cellular Biology, Center for Anatomy and Cell Biology,  Medical University of Vienna, Vienna 1090, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Thomas","sequence":"additional","affiliation":[{"name":"Laboratory for Molecular Cellular Biology, Center for Anatomy and Cell Biology,  Medical University of Vienna, Vienna 1090, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor","family":"Lucas","sequence":"additional","affiliation":[{"name":"Laboratory for Molecular Cellular Biology, Center for Anatomy and Cell Biology,  Medical University of Vienna, Vienna 1090, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mouldy","family":"Sioud","sequence":"additional","affiliation":[{"name":"Department of Immunology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, Oslo N-0310, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyedhossein","family":"Aharinejad","sequence":"additional","affiliation":[{"name":"Laboratory for Molecular Cellular Biology, Center for Anatomy and Cell Biology,  Medical University of Vienna, Vienna 1090, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6337-0058","authenticated-orcid":false,"given":"Dietmar","family":"Abraham","sequence":"additional","affiliation":[{"name":"Laboratory for Molecular Cellular Biology, Center for Anatomy and Cell Biology,  Medical University of Vienna, Vienna 1090, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2013,9,3]]},"reference":[{"key":"ref_1","first-page":"11","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA: A Cancer J. Clin"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.eururo.2011.04.038","article-title":"New therapies for castration-resistant prostate cancer: Efficacy and safety","volume":"60","author":"Beltran","year":"2011","journal-title":"Eur. Urol"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.eururo.2011.08.026","article-title":"Contemporary role of androgen deprivation therapy for prostate cancer","volume":"61","author":"Pagliarulo","year":"2012","journal-title":"Eur. Urol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12094-012-0780-8","article-title":"Castration-resistant metastatic prostate cancer: Current status and treatment possibilities","volume":"14","author":"Carles","year":"2012","journal-title":"Clin. Transl. Oncol"},{"key":"ref_5","first-page":"401","article-title":"Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma","volume":"143","author":"Weidner","year":"1993","journal-title":"Am. J. Pathol"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1046\/j.1432-0436.2002.700902.x","article-title":"Role of stroma in carcinogenesis of the prostate","volume":"70","author":"Cunha","year":"2002","journal-title":"Differentiation"},{"key":"ref_9","first-page":"482","article-title":"Cancer associated fibroblasts: The dark side of the coin","volume":"1","author":"Cirri","year":"2011","journal-title":"Am. J. Cancer Res"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/B978-0-12-397927-8.00009-9","article-title":"Targeting the tumor stroma as a novel therapeutic approach for prostate cancer","volume":"65","author":"Franco","year":"2012","journal-title":"Adv. Pharmacol"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.cardiores.2004.12.002","article-title":"The biology of vascular endothelial growth factors","volume":"65","author":"Tammela","year":"2005","journal-title":"Cardiovasc Res"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00441-003-0776-3","article-title":"VEGF and PlGF: Two pleiotropic growth factors with distinct roles in development and homeostasis","volume":"314","author":"Tjwa","year":"2003","journal-title":"Cell Tissue Res"},{"key":"ref_13","first-page":"79","article-title":"Genetic dissection of tumor angiogenesis: Are PlGF and VEGFR-1 novel anti-cancer targets?","volume":"1654","author":"Luttun","year":"2004","journal-title":"Biochim Biophys. Acta"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3858\/emm.2012.44.1.025","article-title":"The discovery of placenta growth factor and its biological activity","volume":"44","year":"2012","journal-title":"Exp. Mol. Med"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-1-4615-0119-0_7","article-title":"The interaction of Neuropilin-1 and Neuropilin-2 with tyrosine-kinase receptors for VEGF","volume":"515","author":"Neufeld","year":"2002","journal-title":"Adv. Exp. Med. Biol"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nm884","article-title":"Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1","volume":"9","author":"Autiero","year":"2003","journal-title":"Nat. Med"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/87904","article-title":"Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions","volume":"7","author":"Carmeliet","year":"2001","journal-title":"Nat. Med"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Dewerchin, M., and Carmeliet, P. (2012). PlGF: A multitasking cytokine with disease-restricted activity. Cold Spring Harb Perspect. Med.","DOI":"10.1101\/cshperspect.a011056"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cell.2007.08.038","article-title":"Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels","volume":"131","author":"Fischer","year":"2007","journal-title":"Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1158\/1541-7786.MCR-06-0141","article-title":"Down-regulation of placenta growth factor by promoter hypermethylation in human lung and colon carcinoma","volume":"5","author":"Xu","year":"2007","journal-title":"Mol. Cancer Res"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.cell.2013.01.036","article-title":"Targeting placental growth factor\/neuropilin 1 pathway inhibits growth and spread of medulloblastoma","volume":"152","author":"Snuderl","year":"2013","journal-title":"Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ccr.2011.05.007","article-title":"Loss or inhibition of stromal-derived PlGF prolongs survival of mice with imatinib-resistant Bcr-Abl1(+) leukemia","volume":"19","author":"Schmidt","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1158\/0008-5472.CAN-04-3085","article-title":"Placenta growth factor overexpression inhibits tumor growth, angiogenesis, and metastasis by depleting vascular endothelial growth factor homodimers in orthotopic mouse models","volume":"66","author":"Xu","year":"2006","journal-title":"Cancer Res"},{"key":"ref_24","first-page":"3767","article-title":"Placental growth factor gene expression in human prostate cancer and benign prostate hyperplasia","volume":"23","author":"Matsumoto","year":"2003","journal-title":"Anticancer Res"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S8756-3282(03)00195-9","article-title":"Bone morphogenetic protein 2 induces placental growth factor in mesenchymal stem cells","volume":"33","author":"Marrony","year":"2003","journal-title":"Bone"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/jcp.24244","article-title":"Enhancement of placenta growth factor expression by oncostatin M in human rheumatoid arthritis synovial fibroblasts","volume":"228","author":"Tu","year":"2013","journal-title":"J. Cell Physiol"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2007.12.012","article-title":"VEGF function for upregulation of endogenous PlGF expression during FGF-2-mediated therapeutic angiogenesis","volume":"200","author":"Fujii","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"R187","DOI":"10.1530\/ERC-12-0085","article-title":"The reactive stroma microenvironment and prostate cancer progression","volume":"19","author":"Barron","year":"2012","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1002\/stem.1251","article-title":"Inhibition of TGF-beta\/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects","volume":"30","author":"Shangguan","year":"2012","journal-title":"Stem Cells"},{"key":"ref_30","first-page":"517","article-title":"Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic","volume":"76","author":"Ziche","year":"1997","journal-title":"Lab. Invest"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cell.2010.01.033","article-title":"PlGF blockade does not inhibit angiogenesis during primary tumor growth","volume":"141","author":"Bais","year":"2010","journal-title":"Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1073\/pnas.1109029108","article-title":"Expression of a functional VEGFR-1 in tumor cells is a major determinant of anti-PlGF antibodies efficacy","volume":"108","author":"Yao","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ccr.2005.09.005","article-title":"Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors","volume":"8","author":"Casanovas","year":"2005","journal-title":"Cancer Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1038\/nature08254","article-title":"VEGFR1-activity-independent metastasis formation","volume":"461","author":"Dawson","year":"2009","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0014-5793(03)00224-2","article-title":"The unfolding tale of PECAM-1","volume":"540","author":"Jackson","year":"2003","journal-title":"FEBS Lett"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.yexcr.2005.11.012","article-title":"Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis","volume":"312","author":"Shibuya","year":"2006","journal-title":"Exp. Cell. Res"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"22272","DOI":"10.1074\/jbc.273.35.22272","article-title":"Neuropilin-1 is a placenta growth factor-2 receptor","volume":"273","author":"Migdal","year":"1998","journal-title":"J. Biol. Chem"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1158\/1078-0432.CCR-10-2687","article-title":"Placental growth factor upregulation is a host response to antiangiogenic therapy","volume":"17","author":"Bagley","year":"2011","journal-title":"Clin. Cancer Res"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/bjc.2011.609","article-title":"A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours","volume":"106","author":"Lassen","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.clinthera.2011.08.007","article-title":"Monoclonal antibody TB-403: A first-in-human, Phase I, double-blind, dose escalation study directed against placental growth factor in healthy male subjects","volume":"33","author":"Riisbro","year":"2011","journal-title":"Clin. Ther"},{"key":"ref_41","first-page":"53","article-title":"Nanomaterials as non-viral siRNA delivery agents for cancer therapy","volume":"3","author":"Singh","year":"2013","journal-title":"Bioimpacts"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nbt.2614","article-title":"Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling","volume":"31","author":"Sahay","year":"2013","journal-title":"Nat. Biotechnol"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.2741\/3100","article-title":"Host CD147 blockade by small interfering RNAs suppresses growth of human colon cancer xenografts","volume":"13","author":"Abraham","year":"2008","journal-title":"Front. Biosci"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1158\/0008-5472.CAN-06-2295","article-title":"Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway","volume":"67","author":"Zins","year":"2007","journal-title":"Cancer Res"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ab.2010.02.036","article-title":"Reversible ponceau staining as a loading control alternative to actin in Western blots","volume":"401","author":"Ocon","year":"2010","journal-title":"Anal. Biochem"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/14\/9\/17958\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:49:01Z","timestamp":1760219341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/14\/9\/17958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,3]]},"references-count":45,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,9]]}},"alternative-id":["ijms140917958"],"URL":"https:\/\/doi.org\/10.3390\/ijms140917958","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,3]]}}}